Related references
Note: Only part of the references are listed.Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation
Junya Kanda
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)
Yoshiko Atsuta
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia
Seitaro Terakura et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey
Rika Sakai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation
Stephen Harnicar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation
Nelli Bejanyan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
Margaret L. MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation
Laurent Pascal et al.
BLOOD (2015)
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases
H. Yamamoto et al.
BONE MARROW TRANSPLANTATION (2015)
Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: What we do and do not know
M. Ogata et al.
BONE MARROW TRANSPLANTATION (2015)
Prophylactic and therapeutic treatment of graft-versus-host disease in Japan
Makoto Murata
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2015)
Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies
L. Pascal et al.
BONE MARROW TRANSPLANTATION (2015)
Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome
Caroline A. Lindemans et al.
BLOOD (2014)
Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan
Minako Iida et al.
CLINICAL TRANSPLANTATION (2014)
Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-disease - Systematic review and meta-analysis
Ron Ram et al.
LEUKEMIA RESEARCH (2014)
Impact of the Direction of HLA Mismatch on Transplantation Outcomes in Single Unrelated Cord Blood Transplantation
Junya Kanda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Clinical Factors Predicting the Response of Acute Graft-versus-Host Disease to Corticosteroid Therapy: An Analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation
Makoto Murata et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Umbilical cord blood transplantation: the first 25 years and beyond
Karen K. Ballen et al.
BLOOD (2013)
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis
M. E. Scheurer et al.
BONE MARROW TRANSPLANTATION (2013)
Comparison of Unrelated Cord Blood Transplantation and HLA-Mismatched Unrelated Bone Marrow Transplantation for Adults with Leukemia
Yoshiko Atsuta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Graft source determines human hematopoietic progenitor distribution pattern within the CD34+ compartment
C. Arber et al.
BONE MARROW TRANSPLANTATION (2011)
Mycophenolate and Tacrolimus for Graft-Versus-Host Disease Prophylaxis for Elderly After Cord Blood Transplantation: A Matched Pair Comparison With Tacrolimus Alone
Naoyuki Uchida et al.
TRANSPLANTATION (2011)
Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation
Mohamad Mohty et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis
Janelle Perkins et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis
Mary Eapen et al.
LANCET ONCOLOGY (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
Yoshiko Atsuta et al.
BLOOD (2009)
Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system
Yoshiko Atsuta et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults
H. Narimatsu et al.
BONE MARROW TRANSPLANTATION (2007)
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation
RA Nash et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies
S Takahashi et al.
BLOOD (2004)
Outcomes of unrelated cord blood transplantation in pediatric recipients
J Styczynski et al.
BONE MARROW TRANSPLANTATION (2004)
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia
MJ Laughlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia
V Rocha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
B Bolwell et al.
BONE MARROW TRANSPLANTATION (2004)
Optimistic expectations and survival after hematopoietic stem cell transplantation
SJ Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis
H Nishihira et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts
K Theilgaard-Mönch et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
